Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 8/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | GCGR | P47871 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 4/20 | 0.34 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25818397 | 0.94 | PDK2 (0.41) | PDK2ALDH1A1MAPK1AKR1A1AKR1B1 | |
| SCHEMBL19869566 | 0.87 | ALDH1A1 (0.44) | PDK2ALDH1A1MAPK1 | |
| SCHEMBL31461588 | 0.87 | ALDH1A1 (0.44) | PDK2ALDH1A1MAPK1 | |
| SCHEMBL29577059 | 0.84 | ALDH1A1 (0.44) | PDK2ALDH1A1MAPK1 | |
| SCHEMBL14508335 | 0.84 | ALDH1A1 (0.44) | PDK2ALDH1A1MAPK1 | |
| SCHEMBL29789018 | 0.84 | ALDH1A1 (0.44) | PDK2ALDH1A1MAPK1 | |
| SCHEMBL16475932 | 0.83 | PDK2 (0.38) | PDK2AKR1A1AKR1B1PGRS100A4 | |
| SCHEMBL22920886 | 0.83 | PDK2 (0.41) | PDK2ALDH1A1MAPK1AKR1A1AKR1B1 | |
| SCHEMBL27241792 | 0.82 | PGR (0.43) | PDK2PGR | |
| SCHEMBL14508322 | 0.82 | ALDH1A1 (0.45) | PDK2ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | OR10J3, AOC2, EPCAM | PDK2 1256/4885ALDH1A1 489/4885MAPK1 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.